


Pharma Companies’ Disconnect Between Strategy And Execution – Part1 – Asrar Qureshi’s Blog Post #1339
Dear Colleagues! This is Asrar Qureshi’s Blog Post #1339 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com for publishing your contributions here.
Preamble
A pharmaceutical company announces an ambitious strategy: grow market share, launch new products, expand into new therapeutic areas, increase exports, strengthen its field force and improve customer engagement. The CEO communicates the growth agenda. The commercial director prepares ambitious sales targets. Marketing develops brand plans. The organisation is energised by the possibilities.
But when execution begins, a different reality emerges. Finance questions the proposed marketing expenditure. Supply chain resists increasing inventory because of working-capital constraints. Procurement delays investment in new equipment. Human resources is reluctant to approve additional positions. IT takes months to implement systems required by the commercial team. The growth strategy continues to exist in presentations, business plans and management meetings, but its execution becomes increasingly difficult.
This is a familiar situation in many pharmaceutical companies. The commercial organisation is focused on growth, while support departments are primarily concerned with controlling costs, conserving resources and minimising risks.
The problem is not that one side is right and the other wrong. Growth requires resources, while financial discipline and operational efficiency are essential for sustainability. The real problem is that different departments are pursuing their own objectives without a shared understanding of the organisation’s overall strategic priorities. This disconnect between strategy and execution can become one of the most expensive management weaknesses in a pharmaceutical company.
When Strategy Wants Growth but Operations Want to Save: Bridging the Execution Gap in Pharmaceutical Companies
Why the disconnect between commercial ambition and support-function priorities undermines business performance—and how pharmaceutical leaders can turn organisational alignment into a competitive advantage.
The Fundamental Problem: Departmental Priorities Replace Corporate Priorities
Every department has legitimate responsibilities.
- Sales wants adequate resources to achieve ambitious targets.
- Marketing wants investment in brand building, market research and promotional activities.
- Finance wants profitability, cash-flow discipline and cost control.
- Supply chain wants optimum inventory, efficient procurement and minimum wastage.
- Human resources wants controlled manpower costs and organisational efficiency.
- Manufacturing wants production stability, quality compliance and capacity utilisation.
There is nothing inherently wrong with these priorities. The difficulty arises when departmental objectives become more important than corporate objectives.
For example, the commercial team may identify a significant opportunity to increase sales by expanding product availability in smaller cities. However, the supply chain department may resist increasing inventory because it wants to minimise stockholding. Finance may reject additional promotional expenditure because it is evaluated primarily on budget control. HR may delay recruitment because it is trying to maintain a predetermined headcount. Each department may successfully achieve its own targets, yet the company may fail to achieve its growth ambitions.
This is a classic example of sub-optimisation: individual functions perform according to their own objectives, but the organisation as a whole does not achieve the best possible result. A company does not become successful simply because all its departments are individually efficient. It becomes successful when all departments contribute to the same corporate priorities.
The Implications of This Disconnect
The consequences extend far beyond departmental disagreements. They affect market competitiveness, financial performance, customer satisfaction and organisational culture.
Growth opportunities are lost: Pharmaceutical markets are dynamic. New competitors enter, doctors change prescribing preferences, regulatory requirements evolve and new therapeutic opportunities emerge. Commercial teams need the flexibility to respond quickly. Suppose a company identifies an opportunity to launch a new formulation in a growing therapeutic segment. The marketing team prepares the business case, but manufacturing capacity is not prioritised, procurement takes too long to source materials and finance is unwilling to approve the required investment. By the time the company is ready, competitors may have established their positions. The opportunity has not necessarily disappeared because the strategy was wrong. It has disappeared because the organisation could not execute it in time.
Sales targets become disconnected from operational capabilities: A company may set an ambitious sales growth target without ensuring that the supply chain, manufacturing capacity, distribution network and working capital can support it. The sales force is then held accountable for targets that the organisation has not equipped it to achieve. Stock shortages, delayed deliveries and poor product availability frustrate customers and damage commercial credibility.
Financial control becomes an obstacle rather than an enabler: Finance has an essential role in protecting organisational resources. However, when financial management is interpreted primarily as expenditure reduction, it can unintentionally undermine profitable growth. Consider two marketing investments: One generates a measurable improvement in sales and market share. Another produces little commercial return. A sensible finance function should help management distinguish between these investments. But if the main objective is to reduce expenditure across the board, both may be treated similarly. This creates a dangerous situation in which the company saves money on activities that could have generated significantly greater returns. The distinction between cost and investment becomes blurred.
Organisational silos become stronger: When departments are judged primarily on their own performance indicators, they naturally protect their budgets, resources and responsibilities. Commercial managers may blame supply chain for stock shortages. Supply chain may blame sales for inaccurate forecasts. Finance may blame marketing for overspending. Marketing may blame finance for insufficient investment. Meetings become exercises in defending departmental positions rather than solving business problems. Over time, employees begin to identify more strongly with their departments than with the organisation. This weakens collaboration and makes cross-functional execution increasingly difficult.
Customer experience deteriorates: Customers do not see a pharmaceutical company as separate departments. They experience one organisation. A doctor expects product availability, reliable information and professional engagement. A distributor expects timely supplies, predictable commercial policies and responsive service. A hospital expects dependable deliveries and appropriate documentation. If internal departments are poorly coordinated, the customer experiences the consequences. The organisation may have an excellent product portfolio and a strong sales force, but poor execution can damage its reputation.
Employees become frustrated and disengaged: Nothing is more demotivating for a commercial team than being held responsible for results while repeatedly being denied the resources needed to achieve them. Similarly, support-function employees may feel that commercial colleagues do not understand financial constraints, regulatory obligations or operational risks. Both groups develop frustration and mistrust. The result is an organisation in which departments spend more energy negotiating with one another than serving customers and achieving business objectives.
Why Does This Disconnect Occur?
Understanding the underlying causes is essential before attempting to correct the problem.
- Strategy is developed without adequate functional participation. In most companies, strategy is formulated mainly by the commercial leadership. Finance, supply chain, manufacturing, HR and IT are involved later, when they are expected to provide the resources required for implementation. This creates a fundamental problem. Support departments have not participated in defining the strategy, evaluating its feasibility or understanding the assumptions behind it. They may therefore regard the growth plan as an unrealistic commercial ambition rather than a corporate commitment.
- Departmental KPIs encourage conflicting behaviour. Performance indicators strongly influence managerial behaviour. If finance managers are rewarded mainly for reducing expenditure, they will naturally resist additional spending. If supply chain managers are measured primarily on reducing inventory, they may hesitate to hold the additional stock needed to support growth. If commercial managers are rewarded only on sales, they may push for discounts, credit or promotional expenditure without fully considering profitability and cash flow. The organisation is effectively encouraging different departments to pursue conflicting outcomes.
- Budgets are treated as rigid limits. Annual budgeting is necessary, but markets do not always behave according to annual plans. A new competitor may enter unexpectedly. A product may experience faster-than-anticipated growth. A regulatory development may create a new opportunity. If budgets cannot be reviewed or adjusted when circumstances change, organisations lose the ability to respond. Financial discipline should not mean an inability to reallocate resources.
- Support functions are viewed as cost centres. This is an outdated way of thinking. Finance, HR, IT, procurement and supply chain are not merely administrative departments. They are strategic contributors to business performance. A well-managed supply chain can increase sales by improving product availability. An effective finance function can identify profitable growth opportunities. HR can strengthen sales-force capability. IT can improve customer engagement and forecasting. Their contribution should be evaluated in terms of the value they create, not merely the expenditure they control.
Concluded.
Disclaimers: Pictures in these blogs are taken from free resources at Pexels, Pixabay, Unsplash, and Google. Credit is given where available. If a copyright claim is lodged, we shall remove the picture with appropriate regrets.
For most blogs, I research from several sources which are open to public. Their links are mentioned under references. There is no intent to infringe upon anyone’s copyrights. If, any claim is lodged, it will be acknowledged and duly recognized immediately.







